Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Renal Effects of Sodium-Glucose Co-Transporter Inhibitors
Scott C. Thomson, Volker Vallon
The American Journal of Cardiology (2019) Vol. 124, pp. S28-S35
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
Ralph A. DeFronzo, William Reeves, Alaa S. Awad
Nature Reviews Nephrology (2021) Vol. 17, Iss. 5, pp. 319-334
Closed Access | Times Cited: 392
The tubular hypothesis of nephron filtration and diabetic kidney disease
Volker Vallon, Scott C. Thomson
Nature Reviews Nephrology (2020) Vol. 16, Iss. 6, pp. 317-336
Open Access | Times Cited: 324
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3651-3651
Open Access | Times Cited: 149
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
Clifford J. Bailey, Caroline Day, Srikanth Bellary
Current Diabetes Reports (2022) Vol. 22, Iss. 1, pp. 39-52
Open Access | Times Cited: 140
Glucose transporters in the kidney in health and disease
Volker Vallon
Pflügers Archiv - European Journal of Physiology (2020) Vol. 472, Iss. 9, pp. 1345-1370
Open Access | Times Cited: 102
Renoprotective mechanisms of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease
Sreenithya Ravindran, Shankar Munusamy
Journal of Cellular Physiology (2021) Vol. 237, Iss. 2, pp. 1182-1205
Closed Access | Times Cited: 61
Functional and Clinical Importance of SGLT2-inhibitors in Frailty: From the Kidney to the Heart
Gaetano Santulli, Fahimeh Varzideh, Imma Forzano, et al.
Hypertension (2023) Vol. 80, Iss. 9, pp. 1800-1809
Open Access | Times Cited: 39
The Interplay between Immune and Metabolic Pathways in Kidney Disease
Lili Qu, Baihai Jiao
Cells (2023) Vol. 12, Iss. 12, pp. 1584-1584
Open Access | Times Cited: 30
SGLT2-independent effects of canagliflozin on NHE3 and mitochondrial complex I activity inhibit proximal tubule fluid transport and albumin uptake
Wafaa N. Albalawy, Elynna B. Youm, Katherine E. Shipman, et al.
AJP Renal Physiology (2024) Vol. 326, Iss. 6, pp. F1041-F1053
Closed Access | Times Cited: 6
Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Serum Electrolyte Levels in Patients with Type 2 Diabetes: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials
Jingjing Zhang, Yonghong Huan, Mark R. Leibensperger, et al.
Kidney360 (2022) Vol. 3, Iss. 3, pp. 477-487
Open Access | Times Cited: 23
Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis
Eun Sil Koh, Gheun‐Ho Kim, Sungjin Chung
Endocrinology and Metabolism (2023) Vol. 38, Iss. 4, pp. 359-372
Open Access | Times Cited: 13
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care
Alfredo Caturano, Raffaele Galiero, Maria Rocco, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2039-2039
Open Access | Times Cited: 5
SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 Patients
Evan C. Ray, Cary R. Boyd‐Shiwarski, Pengfei Liu, et al.
Kidney Medicine (2020) Vol. 2, Iss. 3, pp. 359-364
Open Access | Times Cited: 38
Mechanisms of action of SGLT2 inhibitors and their beneficial effects on the cardiorenal axis
Edoardo Gronda, Gary D. Lopaschuk, Arduino Arduini, et al.
Canadian Journal of Physiology and Pharmacology (2022) Vol. 100, Iss. 2, pp. 93-106
Closed Access | Times Cited: 21
Gene knockout of the Na+-glucose cotransporter SGLT2 in a murine model of acute kidney injury induced by ischemia-reperfusion
Josselin Nespoux, Rohit Patel, Haiyan Zhang, et al.
AJP Renal Physiology (2020) Vol. 318, Iss. 5, pp. F1100-F1112
Open Access | Times Cited: 32
Human Glucose Transporters in Renal Glucose Homeostasis
Aleksandra Sędzikowska, Leszek Szablewski
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13522-13522
Open Access | Times Cited: 26
Therapeutic Potential of Mesenchymal Stem Cells in a Pre-Clinical Model of Diabetic Kidney Disease and Obesity
Christian Sávio-Silva, Poliana E. Soinski-Sousa, Antônio Simplício-Filho, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1546-1546
Open Access | Times Cited: 24
Tubuloglomerular Feedback Synchronization in Nephrovascular Networks
Tayyaba Zehra, William A. Cupples, Branko Braam
Journal of the American Society of Nephrology (2021) Vol. 32, Iss. 6, pp. 1293-1304
Open Access | Times Cited: 24
Empagliflozin and Renal Sodium-Hydrogen Exchange in Healthy Subjects
Edoardo Biancalana, Chiara Rossi, Francesco Raggi, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 8, pp. e567-e573
Open Access | Times Cited: 9
Evolving understanding of cardiovascular protection by SGLT2 inhibitors: focus on renal protection, myocardial effects, uric acid, and magnesium balance
Evan C. Ray
Current Opinion in Pharmacology (2020) Vol. 54, pp. 11-17
Open Access | Times Cited: 22
SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease
Swetha Rani Kanduri, Karthik Kovvuru, Panupong Hansrivijit, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2723-2723
Open Access | Times Cited: 21
Renal Tubular Handling of Glucose and Fructose in Health and Disease
Volker Vallon, Takahiko Nakagawa
Comprehensive physiology (2021), pp. 2995-3044
Open Access | Times Cited: 20
Evolution of Type 2 Diabetes Management from a Glucocentric Approach to Cardio-Renal Risk Reduction: The New Paradigm of Care
Stephan Jacob, Andrew J. Krentz, John Deanfield, et al.
Drugs (2021) Vol. 81, Iss. 12, pp. 1373-1379
Closed Access | Times Cited: 19
Changes in Proximal Tubular Reabsorption Modulate Microvascular Regulation via the TGF System
Shayan Poursharif, Shereen Hamza, Branko Braam
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11203-11203
Open Access | Times Cited: 12
Investigation of MHR-nephropathy relationship and the effect of SGLT2is on MHR in patients with type 2 diabetes
Bedriye Gizem Tekin, Erengül Pektaş
Irish Journal of Medical Science (1971 -) (2024) Vol. 193, Iss. 3, pp. 1283-1287
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top